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Primary hepatic lymphoma (PHL) is rare, accounting for less than 1% of all
extranodal lymphomas. In this article, we retrospectively reviewed the
imaging features of 12 pathologically proven cases of primary hepatic
lymphoma.
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Introduction
Non-Hodgkin lymphoma is frequently seen in the liver as
part of the spectrum of widespread disease. Primary
hepatic lymphoma (PHL) is, however, rare, representing
less than 1% of all extranodal lymphomas.1,2 Primary
hepatic lymphoma presents with abdominal pain, fati-
gue, weight loss and a mass with or without jaundice.
There is a male to female preponderance,2 and pre-
sentation is largely in middle age. The pathologic diag-
nosis is usually diffuse large cell lymphoma or large
B-cell lymphoma,3,4 or immunoblastic lymphoma in
immunosuppressed patients, in whom the incidence is
increased.5
Materials and methods
We retrospectively reviewed the imaging findings of
patients with a histological diagnosis of PHL between
1996 and 2001. The study population consisted of 12
patients (nine men and three women), with a mean age
of 63 years. Presenting symptoms or signs included right
upper quadrant pain (five), laboratory abnormalities
(five), constitutional symptoms (two) and gastrointesti-
nal symptoms (two). One patient was HIV positive.
Eight patients had CT examinations and 10 patients
had ultrasound. Imaging characteristics and differential
diagnostic considerations of PHL are presented.
Results
During the 5-year period, 12 patients who satisfied the
criteria for PHL, as described by Lei et al.,3 underwent
either ultrasound or CT examinations. Three of the 12
patients presented with a single focal lesion (Fig. 1).
Eight of 12 patients presented with multiple well-defined
lesions (Fig. 2). One patient presented with a diffuse
hepatic involvement (Fig. 3).
Fig. 1. Axial contrast enhanced CT shows a single 3 ¥ 4 cm heterogeneous
hypoattenuating lesion (arrow) with areas of central necrosis.
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All eight patients who underwent CT evaluation dem-
onstrated hypoattenuating solid lesions. Most of these
were well-defined lesions (Fig. 4). The lesions of three
patients demonstrated rim enhancement following intra-
venous iodinated contrast administration (Fig. 5). Three
patients demonstrated target lesions on CT, with a
hypoattenuating halo and central necrosis (Fig. 6).
All 10 patients who underwent ultrasound evaluation
demonstrated solid appearing lesions, which were hypo-
echoic when compared with the adjacent liver (Fig. 7).
In five patients, some or all of the lesions demonstrated
a ‘target’ appearance on ultrasound imaging (Fig. 8).
Fluorine-18-fluoro-2-deoxyglucose positron emission
tomography (PET) was performed in one patient and
demonstrated markedly increased uptake of the lym-
phomatous deposits (Fig. 9).
Discussion
Primary hepatic lymphoma represents a rare mani-
festation of the lymphoma spectrum.6,7 Presentation is
(a)
(b)
Fig. 2. (a) Ultrasound and (b) contrast enhanced axial CT images in a 67-year-
old with abdominal pain show multiple well-defined hypoattenuating and
hypoechoic lesions.
Fig. 3. Contrast-enhanced CT image shows diffuse heterogeneous ill-defined
coalescent lesions in a 56-year-old woman with liver failure.
Fig. 4. Contrast enhanced CT shows two well defined lesions in the lateral
segment of the left hepatic lobe (arrows).
Fig. 5. Contrast enhanced CT shows a 1.9 cm well-defined ring enhancing
lesion in the right hepatic lobe.
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Fig. 6. (a,b) Contrast enhanced CT in a 58-year-old with 20 lb weight loss shows lesions with hypoattenuating halos (arrows) surrounding enhancing intermediate
zones. There is central hypoattenuating necrosis (arrowheads). The overall effect is of a target sign.
(a) (b)
(c)
Fig. 7. (a–c) Ultrasound images in three different patients show well-defined hypoechoic lesions.
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common during middle age, largely in the male popula-
tion.8 Typical presenting complaints include right upper
quadrant pain, nausea, vomiting and weight loss.2
Patients who present late often complain of a right upper
quadrant mass or of hepatic fullness. Lactate dehydro-
genase and alkaline phosphatase are sometimes
elevated.4 Alpha-fetoprotein and carcinoembryonic
antigen are often normal.4,9 Hypercalcaemia may also be
present.9 Immunosuppression increases the risk of non-
Hodgkin’s lymphoma. There is an association with infec-
tions with hepatitis C and hepatitis B viruses.10–12
The tumours are generally non-Hodgkin’s in type.
Diffuse large cell lymphoma is the most commonly
encountered histological subtype.13 Almost invariably,
the tumour is composed of lymphocytes reacting with
B-cell markers. Most cases are intermediate or high
grade according to the classification of the working for-
mulation for clinical usage. AIDS-related non-Hodgkin’s
lymphomas are considered highly aggressive and can
include small non-cleaved, large immunoblastic and
undifferentiated cell types.5,14
Our results confirm previous reports that PHL can
present as a solitary mass or as multiple discrete
masses.15,16 Three of our eight patients demonstrated a
single hepatic mass, and eight demonstrated multiple
masses. Rarely, the disease presents as diffuse involve-
ment of the liver.17 From our series of 12 patients, there
was one case of diffuse disease. Our findings are con-
cordant with previous papers describing the ultrasound
appearances as of well-defined hypoechoic masses15,17
Our findings are also consistent with previous descrip-
tions of hepatic lymphoma as of low attenuation on
(a) (b)
(c)
Fig. 8. Ultrasound images in three different patients show multiple lesions with hyperechoic centers and hypoechoic rims (arrows), creating a target appearance.
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CT.15,17,18 Rim enhancement has also been previously
described.15 There was no calcification in our series.
Calcification has been previously described.15,18
However, intravenous contrast was used in all of our
cases, possibly resulting in obscuration of small foci
of calcification. There are no previous reports, to our
knowledge, describing the target appearances we iden-
tified in three of our eight patients at CT and in five of
our 10 patients at ultrasound.
The criteria for establishing the diagnosis of PHL include
both clinical and histopathological factors. In addition to
histological evidence of hepatic lymphoma, Lei et al.3
described the following criteria to establish the diagnosis:
1 Signs and symptoms related to liver involvement at
presentation including laboratory abnormalities and
right upper quadrant mass or pain
2 Absence at presentation of palpable adenopathy and
no radiologically evident distant lymphadenopathy
3 Absence of leukaemia on peripheral smear
Fluorine-18-fluoro-2-deoxyglucose PET is frequently uti-
lised with lymphoma. The majority of lymphomatous
(a) (b)
(c)
Fig. 9. 50-year-old male patient with primary hepatic lymphoma that showed (a) conglomerate low attenuation on contrast enhanced CT and (b,c) increased uptake
on FDG PET.
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deposits should demonstrate increased uptake, and the
level of uptake may correlate with disease activity and
tumour proliferation.19 This is concordant with the
finding of increased uptake when PET was studied in a
single case of our series.
The imaging appearance of hepatic lymphoma is non-
specific and mainly includes hypovascular metastatic
deposits. Colon, lung, prostate, gastric and transitional
cell carcinomas are the most common primary tumours
with hypovascular metastases to the liver.20 Infectious
(such as fungal and microbacterial) and inflammatory
(such as sarcoidosis) pathologies can sometimes result
in similar imaging appearances with multiple focal
hepatic lesions, but clinical and laboratory values can
often help in their differentiation.
There is little consistency in the literature regarding
treatment of PHL.21 The prognosis is generally perceived
as dismal, with early disease recurrence at extra-hepatic
locations and an overall short survival.3 Reported median
survival is as low as 6 months for patients treated with
chemotherapy alone. Surgery and combination chemo-
therapy, either alone or with radiation, have all been
described as viable management options. While there is
little consistency in recommendations for management,
recent studies indicate improved remission rates with
combination chemotherapy.4 High risk factors at the
time of diagnosis include patient age, bulky disease and
comorbidities, such as active hepatitis or cirrhosis. Given
these factors, early detection is vital for patient man-
agement.
Conclusion
Primary hepatic lymphoma is a rare form of extranodal
non-Hodgkin’s disease that commonly presents with
non-specific haepatobiliary signs and symptoms. There
is a wide spectrum of imaging findings on CT and ultra-
sound. Like many other hepatic malignancies, PHL
generally presents as hypoattenuating or hypoechoic
lesions. Lesions may be single, multiple or diffuse. Rim
enhancement is occasionally seen. A target appearance
to the lesions on both ultrasound and CT is also seen.
Primary hepatic lymphoma should be considered in the
differential diagnosis of liver lesions when no primary
malignancy is known.
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